Biotech firm's stock incentive plan sees first vesting

Guangzhou Boji Medical & Biotechnological has announced the results of the first vesting period for its 2024 restricted stock incentive plan, involving 22 employees and 1,140,000 shares, representing 0.2973% of the company's total share capital. The shares, priced at CNY 6.61 each, are derived from the company's specifically issued A-shares. The listing and circulation of these shares is scheduled for July 7, 2025. This vesting follows board approval on April 24, 2025, confirming the achievement of pre-set conditions. The funds generated from the shares—totaling CNY 7,535,400—will be used to supplement the company's working capital. Post-vesting, the total share capital will increase to 384,533,803 shares.